Seeing Is Believing
with an average price target of $6.59. This is a potential upside of $2.33 (54.69%) from yesterday's end of day stock price of $4.26.
Checkpoint Therapeutics's activity chart (see below) currently has 16 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 30.83% with an average time for these price targets to be met of 46.5 days.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 31-Mar-2025. First documented stock forecast 29-May-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Jan-2025
$4.8
$0.54 (12.68%)
$4.8
1 years 6 days ago
(31-Mar-2025)
0/3 (0%)
$0.76 (18.81%)
Buy Since 13-Aug-2024
$4.1
$-0.16 (-3.76%)
1 years 26 days ago
(11-Mar-2025)
1/2 (50%)
$0.1 (2.50%)
45
Buy Since 29-May-2019
$4.1
$-0.16 (-3.76%)
$7
1 years 27 days ago
(10-Mar-2025)
2/5 (40%)
$0.12 (3.02%)
117
Buy Since 26-Jan-2022
2 years 7 months 22 days ago
(15-Aug-2023)
1/3 (33.33%)
$8.34 (125.23%)
24
What is CKPT (Checkpoint Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CKPT (Checkpoint Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CKPT (Checkpoint Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CKPT (Checkpoint Therapeutics)?
Which analyst is the currently most bullish on CKPT (Checkpoint Therapeutics)?
Which analyst is the currently most reserved on CKPT (Checkpoint Therapeutics)?